SCAN 2025 – NET patient survey (New Zealand)
The New Zealand reading of the global SCAN 2025 survey of neuroendocrine cancer patients and clinicians – how our care compares with the world.
SCAN (Survey on the Challenges faced by patients and clinicians Affected by NETs) is a global survey run every few years. In 2025, 110 New Zealand patients and 73 clinicians took part. The results show where New Zealand leads – free, nurse-led care and world-class PRRT access – and where we fall behind, on treatment delays and awareness of clinical trials.
View the interactive SCAN 2025 report, or download the full PDF.
Related resources
More like this →
BookletThe invisible cancer: misdiagnosed, misunderstood, managed too late
Our new report, 20 pages, free to read and download. Why neuroendocrine cancer is so often missed in New Zealand, what the delays cost, and the symptoms to look for.
VideoSIRT – Dr Sofiullah Abubakar and Dr Michael Sunderland
A Zoom session on selective internal radiation therapy (SIRT), for anyone who could not join on the night.
VideoUnderstanding neuroendocrine care in New Zealand – Ben Lawrence
How neuroendocrine cancer care is organised in New Zealand, and what that means for the people in it.
VideoMerkel Cell Carcinoma – Ben Lawrence
Merkel Cell Carcinoma, a rare neuroendocrine cancer of the skin, explained for patients and whānau.